HEYLEN FARMA
ActiveSummary
HEYLEN FARMA has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €299,410 and a net result of €22,925. Equity has been growing by about 3.1% per year since 2018. Its solvency ranks better than 48% of 9,537 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.5% (very low).
Overview
Official details
Source: KBO- Status
- Active since 31-05-1991 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2024
- Establishment unit
- 2.053.397.156 3200 Aarschot, since 10-07-1991
- Financial year end
- 31 December
- Peppol
- Reachable since 20-12-2025
Board and ownership
- ANKOFARDirector · since 15-06-2023 · permanent representative HEYLEN Paul
- HEYLEN AnneliesDirector · since 15-06-2023
- ANKOFAR100%· score 8631-03-2025 annual accounts of ANKOFAR
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.5%
- Gross margin
- €299,855
- ▲ 31.5%
- Turnover
- ≈ €1.1m
- estimated
- Profit
- €22,925
- ▼ 38.4%
- Equity
- €299,410
- ▲ 8.3%
- Total assets
- €826,841
- ▲ 39.6%
- Employees on 31-12-2024
- 4
- =
- 2025 accounts not filed, 94 days past the deadline
Score breakdownraises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed on 04-09-2025)1 financial year not filed after the legal deadline; last filed accounts filed 31 days late; 1 of the last 3 accounts latelowers riskFounded in 1991Liquidity: current ratio 3.12, cash €175,749Show the evidence
Checked score
About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 52% of them on solvency, 78% on liquidity, 41% on profitability and 58% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 6 accounts on average 24 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
Key points
- Positive: 6 profitable years in a rowprofit 2024: €22,925 6 years View
Recent changes
- · Gazette deed Company renamed from APOTHEEK RAMAKERS to HEYLEN FARMAResignations: ANKOFAR (director) and VAN DEN BROECK Godelieve (director) · Appointments: ANKOFAR (director) and HEYLEN Annelies (director) · Permanent representative: HEYLEN Paul
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as HEYLEN FARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €814,000 and €901,000, founded between 1988 and 1996.
| Company | Total assets | Gross margin |
|---|---|---|
| HEYLEN FARMA Aarschot | €826,841 | €299,855 |
| ANCIAUX Sint-Pieters-Woluwe | €823,388 | €276,427 |
| APOTHEEK CRAEGHS-DIRKX As | €859,546 | €329,068 |
| PHARDUP Etterbeek | €817,511 | €269,027 |
| APOTHEEK BROECHOVEN Ternat | €863,262 | €308,757 |
| MELON-WISLEZ Waimes | €901,346 | €355,237 |
| APOTHEEK HUSTINGS Zonhoven | €813,763 | €292,022 |
Key facts about HEYLEN FARMA
- What is the company number of HEYLEN FARMA?
- The company number of HEYLEN FARMA is 0444.326.811. The VAT number is the same number with BE in front: BE 0444.326.811.
- Where is HEYLEN FARMA based?
- The registered office is at Leuvensestraat 22, 3200 Aarschot.Company details
- What does HEYLEN FARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of HEYLEN FARMA?
- The legal form of HEYLEN FARMA is Public limited company (NV).
- When was HEYLEN FARMA founded?
- HEYLEN FARMA was founded on 31-05-1991.
- Is HEYLEN FARMA still active?
- Yes, HEYLEN FARMA is an active enterprise in the KBO register.
- How many employees does HEYLEN FARMA have?
- HEYLEN FARMA had an average of 3.9 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- Which joint committee does HEYLEN FARMA fall under?
- In its 2024 annual accounts, HEYLEN FARMA states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of HEYLEN FARMA?
- The turnover in financial year 2024 is ≈ €1.1m. This figure is estimated from the gross margin of €299,855 and 47 comparable companies (NACE 477). It probably lies between €850,000 and €1.8m.
- Is HEYLEN FARMA profitable?
- In financial year 2024, HEYLEN FARMA made a profit of €22,925.
- Where can I find the annual accounts of HEYLEN FARMA?
- HEYLEN FARMA filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.